行情

VYGR

VYGR

Voyager
NASDAQ

实时行情|Nasdaq Last Sale

13.98
+0.26
+1.90%
盘后: 14.28 +0.3 +2.15% 16:40 12/06 EST
开盘
13.78
昨收
13.72
最高
14.15
最低
13.72
成交量
51.05万
成交额
--
52周最高
28.79
52周最低
7.76
市值
5.18亿
市盈率(TTM)
-8.5978
分时
5日
1月
3月
1年
5年

分析师评级

13位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

VYGR 新闻

  • Voyager Therapeutics Enters Sales Agreement With Cowen For $100M Common Stock
  • Benzinga.3天前
  • Gene therapy stocks in focus after Astellas/Audentes deal
  • seekingalpha.3天前
  • Healthcare dominates premarket gainers
  • Seeking Alpha - Article.3天前
  • 意大利最大商业银行拟裁员8000人
  • 新浪财经.3天前

更多

所属板块

生物技术和医学研究
+1.28%
制药与医学研究
+0.68%

热门股票

名称
价格
涨跌幅

VYGR 简况

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company. The Company focuses on developing treatments for patients suffering from severe diseases of the central nervous system (CNS). The Company's pipeline consists of programs for CNS indications, including advanced Parkinson's disease; a monogenic form of amyotrophic lateral sclerosis (ALS); Huntington's disease; Friedreich's ataxia; frontotemporal dementia/Alzheimer's disease, and severe chronic pain. The Company's clinical candidate, VY-AADC01, is an adeno-associated virus (AAV) gene therapy product candidate, for the treatment of advanced Parkinson's disease. VY-AADC01 consists of the AAV2 capsid, which has been used in multiple AAV gene therapy clinical trials for various diseases, and the cytomegalovirus promoter that drives expression of the aromatic L-amino acid decarboxylase (AADC) transgene. Its pipeline also includes VY-SOD101, VY-FXN01, VY-HTT01, VY-TAU01 and VY-NAV01.
展开

Webull提供Voyager Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。